Clinical data
Oral
Legal status
Identifiers
2-(2-ethyl-2,3-dihydro-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
C13H16N2O
216.284 g·mol−1
3D model (JSmol)
N\1=C(\NCC/1)C3(Oc2ccccc2C3)CC
InChI=1S/C13H16N2O/c1-2-13(12-14-7-8-15-12)9-10-5-3-4-6-11(10)16-13/h3-6H,2,7-9H2,1H3,(H,14,15) Y
Key:RATZLMXRALDSJW-UHFFFAOYSA-N Y
Efaroxan is an α2-adrenergic receptor antagonist[1] and antagonist of the imidazoline receptor.
The Darzens reaction between 2-fluorobenzaldehyde [57848-46-1] (1) and Ethyl 2-bromobutyrate [533-68-6] (2) gives ethyl 2-ethyl-3-(2-fluorophenyl)oxirane-2-carboxylate, CID:100942311 (3). A catalytic hydrogenation over Pd/C would give ethyl 2-[(2-fluorophenyl)methyl]-2-hydroxybutanoate, CID:77591056 (4). Saponification of the ester then gives 2-[(2-Fluorophenyl)methyl]-2-hydroxybutanoic acid, CID:53869347 (5). Treatment with 2 molar equivalents of sodium hydride apparently gives 2-Ethyl-2,3-dihydrobenzofuran-2-carboxylic acid [111080-50-3] (6). Treatment of the carboxylic acid with thionyl chloride then gives the acid chloride and subsequent treatment of this with ethylenediamine in the presence of trimethylaluminium completed the synthesis of Efaroxan (8).
Antagonists
Antagonists
Antagonists
IRTooltip Imidazoline receptor
See also: Receptor/signaling modulators